| 000 | 01694 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516055534.0 | ||
| 264 | 0 | _c20120103 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2011-01-331702 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJak, Margot | |
| 245 | 0 | 0 |
_aCD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101. _h[electronic resource] |
| 260 |
_bBlood _cNov 2011 |
||
| 300 |
_a5178-88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aActins _xmetabolism |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCD40 Antigens _xmetabolism |
| 650 | 0 | 4 |
_aCell Death _ximmunology |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _ximmunology |
| 650 | 0 | 4 |
_aLysosomes _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRituximab |
| 700 | 1 | _avan Bochove, Gregor G W | |
| 700 | 1 | _aReits, Eric A | |
| 700 | 1 | _aKallemeijn, Wouter W | |
| 700 | 1 | _aTromp, Jacqueline M | |
| 700 | 1 | _aUmana, Pablo | |
| 700 | 1 | _aKlein, Christian | |
| 700 | 1 | _avan Lier, Rene A W | |
| 700 | 1 | _avan Oers, Marinus H J | |
| 700 | 1 | _aEldering, Eric | |
| 773 | 0 |
_tBlood _gvol. 118 _gno. 19 _gp. 5178-88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2011-01-331702 _zAvailable from publisher's website |
| 999 |
_c21185813 _d21185813 |
||